• DSIP delta sleep inducing peptide lyophilised research vial – Dubai Peptides UAE
1 1

Omni Peptides

DSIP

Dhs. 250.00 AED
Dhs. 250.00 AED
Sale Sold out
CHOOSE YOUR FORMAT

Size
Lyophilised & sealed vials
Independent COA · ≥99% purity
Cold-chain dispatch · same day Dubai
Discreet · unbranded outer packaging

Improves sleep architecture, recovery, stress resilience

DSIP (Delta Sleep-Inducing Peptide, also known as Emideltide or Deltaran) is a synthetic nonapeptide originally isolated from cerebral venous blood of rabbits during induced sleep states. This research compound has attracted considerable scientific interest for its potential roles in sleep regulation, stress adaptation, and neuroendocrine modulation. Preliminary and advanced preclinical studies suggest that DSIP may promote delta-wave (slow-wave) sleep, reduce motor activity, exert stress-protective effects, modulate pain perception, and influence circadian rhythms without typical sedative mechanisms. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of sleep architecture, stress resilience, opioid/alcohol withdrawal, and neuroprotection. As a research-grade compound, DSIP is intended exclusively for in vitro and animal studies. Scientists value its amphiphilic nature, presence in multiple tissues (including brain, pituitary, and peripheral organs), and capacity to provide insights into endogenous hypnogenic and adaptive peptide signaling.

Molecular Formula
C₃₅H₄₈N₁₀O₁₅
Molecular Weight
848.8 g/mol
Sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

Research Applications

01 Sleep Regulation and Architecture
Preclinical investigations demonstrate that DSIP induces spindle and delta EEG activity, enhances slow-wave sleep, and normalizes sleep patterns in various animal models (e.g., rabbits, rats, mice). Studies explore its correlation with circadian rhythms, plasma levels during sleep transitions, and potential to improve sleep efficiency without suppressing REM sleep.
02 Stress Protection and Adaptation
DSIP exhibits robust stress-limiting effects, reducing manifestations of acute and chronic stress, modulating HPA axis activity (e.g., decreasing corticotropin), and enhancing tolerance to psychic and physiological stressors in animal models. Research highlights its role in counteracting withdrawal symptoms from opioids and alcohol.
03 Pain Modulation and Analgesia
Investigations indicate potent antinociceptive properties, particularly with central administration, suggesting interactions with opiate systems and potential benefits in models of chronic pain, neuropathic conditions, and fibromyalgia.
04 Neuroprotection and Antioxidant Effects
DSIP protects against oxidative stress, enhances mitochondrial function (e.g., oxidative phosphorylation), and exhibits neuroprotective actions in models of neurodegeneration, epilepsy (anticonvulsant effects), and age-related decline. Studies also suggest antimutagenic and potential anticarcinogenic activity (e.g., reduced spontaneous tumor incidence in mice).
05 Broader Endocrine and Physiological Effects
Research shows DSIP influences thermoregulation, blood pressure, myocardial function, hormonal release (e.g., stimulating LH and GH while inhibiting somatostatin), and immune modulation, with implications for aging, metabolic health, and recovery from various insults.

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.

Molecular Formula
C₃₅H₄₈N₁₀O₁₅
Molecular Weight
848.8 g/mol
Sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

— About this compound

DSIP is a synthetic nonapeptide.

DSIP (Delta Sleep-Inducing Peptide, also known as Emideltide or Deltaran) is a synthetic nonapeptide originally isolated from cerebral venous blood of rabbits during induced sleep states. This research compound has attracted considerable scientific interest for its potential roles in sleep regulation, stress adaptation, and neuroendocrine modulation. Preliminary and advanced preclinical studies suggest that DSIP may promote delta-wave (slow-wave) sleep, reduce motor activity, exert stress-protective effects, modulate pain perception, and influence circadian rhythms without typical sedative mechanisms. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of sleep architecture, stress resilience, opioid/alcohol withdrawal, and neuroprotection. As a research-grade compound, DSIP is intended exclusively for in vitro and animal studies. Scientists value its amphiphilic nature, presence in multiple tissues (including brain, pituitary, and peripheral organs), and capacity to provide insights into endogenous hypnogenic and adaptive peptide signaling.

VIAL ANATOMY
LYOPHILISED VIAL
Flip-off cap
Tamper-evident seal
Rubber stopper
Bacteriostatic-water compatible
Batch-labelled body
Lot & expiry printed
USP Type I glass
Borosilicate, sealed
DSIP vial
DSIP
10mg
DUBAI PEPTIDES
RESEARCH USE ONLY
BLACK RESEARCH SERIES

Research Applications

Where researchers apply it.

01 Sleep Regulation and Architecture
Preclinical investigations demonstrate that DSIP induces spindle and delta EEG activity, enhances slow-wave sleep, and normalizes sleep patterns in various animal models (e.g., rabbits, rats, mice). Studies explore its correlation with circadian rhythms, plasma levels during sleep transitions, and potential to improve sleep efficiency without suppressing REM sleep.
02 Stress Protection and Adaptation
DSIP exhibits robust stress-limiting effects, reducing manifestations of acute and chronic stress, modulating HPA axis activity (e.g., decreasing corticotropin), and enhancing tolerance to psychic and physiological stressors in animal models. Research highlights its role in counteracting withdrawal symptoms from opioids and alcohol.
03 Pain Modulation and Analgesia
Investigations indicate potent antinociceptive properties, particularly with central administration, suggesting interactions with opiate systems and potential benefits in models of chronic pain, neuropathic conditions, and fibromyalgia.
04 Neuroprotection and Antioxidant Effects
DSIP protects against oxidative stress, enhances mitochondrial function (e.g., oxidative phosphorylation), and exhibits neuroprotective actions in models of neurodegeneration, epilepsy (anticonvulsant effects), and age-related decline. Studies also suggest antimutagenic and potential anticarcinogenic activity (e.g., reduced spontaneous tumor incidence in mice).
05 Broader Endocrine and Physiological Effects
Research shows DSIP influences thermoregulation, blood pressure, myocardial function, hormonal release (e.g., stimulating LH and GH while inhibiting somatostatin), and immune modulation, with implications for aging, metabolic health, and recovery from various insults.

— Verified & Documented

Every vial is backed by a Certificate of Analysis.

Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.

Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.

>99%
HPLC Purity
MS
Identity Confirmed
Certificate of Analysis
DSIP · BATCH DS10-1231 · QC RELEASE
PASS
IdentityConfirmed
Mass12.15 mg
Purity99.61%
AppearanceWhite Lyophilised
LabJanoshik Analytical (Independant)
Date12/01/26

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.